Oric Pharmaceuticals (ORIC) Accumulated Depreciation (2019 - 2026)
Oric Pharmaceuticals' (ORIC) quarterly Accumulated Depreciation came in at $7.9 million in Q1 2026, up 1.86% YoY from $7.8 million in Q1 2025, and up 3.53% on a QoQ basis from $7.7 million in Q4 2025.
Oric Pharmaceuticals (ORIC) Accumulated Depreciation (2019 - 2026) Analysis & Trends
Oric Pharmaceuticals (ORIC) has 8 years of Accumulated Depreciation data on file, last reported at $7.9 million in Q1 2026.
- Quarterly Accumulated Depreciation rose 1.86% year-over-year to $7.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.9 million (up 1.86% YoY) and the FY2025 annual result came in at $7.7 million, up 2.34% from the prior year.
- Accumulated Depreciation grew to $7.9 million in Q1 2026, from $7.7 million in the prior quarter.
- In the past five years, Accumulated Depreciation ranged from a high of $8.2 million in Q3 2025 to a low of $5.2 million in Q1 2022.
- A 5-year average of $6.8 million and a median of $6.7 million in 2024 frame the typical range for Accumulated Depreciation.
- Annual changes were most pronounced in 2025 — Accumulated Depreciation gained 16.62% — and 2026, when it climbed 1.86%.
- Tracing ORIC's Accumulated Depreciation over 5 years: stood at $5.8 million in 2022, then grew by 12.1% to $6.5 million in 2023, then gained by 15.12% to $7.5 million in 2024, then rose by 2.34% to $7.7 million in 2025, then gained by 3.53% to $7.9 million in 2026.
- The last three Accumulated Depreciation figures came in at $7.9 million (Q1 2026), $7.7 million (Q4 2025), and $8.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Oric Pharmaceuticals | 1.44 Bn | 1.44 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.19 Mn |
| Mar 31, 2026 | 7.92 Mn |
| Dec 31, 2025 | 7.65 Mn |
| Sep 30, 2025 | 8.16 Mn |
| Jun 30, 2025 | 8.00 Mn |
| Mar 31, 2025 | 7.78 Mn |
| Dec 31, 2024 | 7.48 Mn |
| Sep 30, 2024 | 7.21 Mn |
| Jun 30, 2024 | 6.94 Mn |
| Mar 31, 2024 | 6.67 Mn |
| Dec 31, 2023 | 6.49 Mn |
| Sep 30, 2023 | 6.56 Mn |
| Jun 30, 2023 | 6.30 Mn |
| Mar 31, 2023 | 6.05 Mn |
| Dec 31, 2022 | 5.79 Mn |
| Sep 30, 2022 | 5.64 Mn |
| Jun 30, 2022 | 5.45 Mn |
| Mar 31, 2022 | 5.23 Mn |
| Dec 31, 2021 | 4.99 Mn |
| Sep 30, 2021 | 4.88 Mn |